Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1995
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189975A1 Peptide-mediated gene transfer
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189421A1 Collagen from cell cultures
11/23/1995CA2188562A1 Method of introducing pathogen resistance in plants
11/23/1995CA2188421A1 Alphavirus expression vector
11/23/1995CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression
11/23/1995CA2186615A1 Novel enzymatic rna molecules
11/23/1995CA2158926A1 Compositions and methods for targeting gene delivery vehicles
11/22/1995EP0683238A2 A process for the cloning of DNA
11/22/1995EP0683230A1 Vitreoscilla haemoglobin promoter/regulator controlled by the level of oxygen
11/22/1995EP0683229A2 Process for the preparation of recombinant aprotinin and recombinant aprotinin variants with natural N-terminal sequence
11/22/1995EP0683228A2 Novel expression system
11/22/1995EP0683227A1 Human retinoic acid receptor and genes encoding for it
11/22/1995EP0683226A1 Transgenic animals as a model for metabolic bone diseases
11/22/1995EP0682950A1 Mucosal administration of pneumococcal antigens
11/22/1995EP0682716A1 Rna assays using rna binary probes and ribozyme ligase
11/22/1995EP0682715A1 Diagnostic assays and kits for rna using rna binary probes and an rna-directed rna ligase
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
11/22/1995EP0682711A1 Plants resistant to infection by plrv
11/22/1995EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products
11/22/1995EP0682709A1 Fusion proteins including a cleavage site recognized by a plant virus protease
11/22/1995EP0682708A1 Antiviral composition of viral protein trans-dominant variants
11/22/1995EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
11/22/1995EP0682706A1 Novel compounds
11/22/1995EP0682705A1 Tnf-alpha muteins and a process for preparing them
11/22/1995EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide
11/22/1995EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
11/22/1995EP0682702A1 Expression of protective antigens
11/22/1995EP0682701A1 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS
11/22/1995EP0682700A1 Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis
11/22/1995EP0682699A1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE
11/22/1995EP0682671A1 Methods and apparatus for dna sequencing
11/22/1995EP0682529A1 Antibody for the treatment of insulin dependent diabetes
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/22/1995EP0571475B1 Sg(beta)-1,4-GALACTANASE AND A DNA SEQUENCE
11/22/1995EP0485608B1 Method for obtaining polypeptides in a cell-free translation system
11/22/1995EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna
11/22/1995CN1112356A Novel attenuated pseudomonas aeruginosa strains
11/22/1995CN1112142A Microcapsule-type curing agent, method for producing the same, thermosetting resin composition, prepreg and fiber reinforced composite material
11/22/1995CN1112127A A novel polypeptide of protein p140 and DNAS encoding it
11/22/1995CN1112126A Polyamid-oligonucleotide derivative, preparation and application of same
11/21/1995US5468851 Construction of geometrical objects from polynucleotides
11/21/1995US5468637 S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones
11/21/1995US5468636 Aphidicides
11/21/1995US5468634 Axl oncogene
11/21/1995US5468631 Genetic engineering
11/21/1995US5468630 cDNA clone for human inducible nitric oxide synthase and process for preparing same
11/21/1995US5468629 Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
11/21/1995US5468624 Polynucleotide with sequyence code and cells
11/21/1995US5468615 Adding a compound to eukaryotic cell transformed with vector capable of expressing human dopamine receptor, assaying affinity of compound for receptor
11/21/1995US5468614 System to detect protein-protein interactions
11/21/1995US5468613 Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids
11/21/1995US5468609 Production of interferon
11/21/1995US5468608 Production of interferon
11/21/1995US5468607 Production of interferon
11/21/1995US5468485 Avirulent microbes and uses therefor
11/21/1995US5468483 Bacillus thuringiensis anti-giardia treatment
11/21/1995US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD
11/21/1995CA2149703A1 Mucosal administration of pneumococcal antigens
11/21/1995CA2149345A1 Epitopic regions of pneumococcal surface protein a
11/21/1995CA1337597C Phosphinotricin-resistance gene, and its use
11/21/1995CA1337596C Varicella-zoster virus as a live recombinant vaccine
11/19/1995CA2149375A1 Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural n-terminal sequence
11/18/1995CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
11/16/1995WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase
11/16/1995WO1995030773A1 Method of nucleic acid transfer
11/16/1995WO1995030772A1 Method of detecting human cytochrome p4502d6 gene polymorphism
11/16/1995WO1995030768A1 Method and apparatus for counting cells and microorganisms, particularly in food and biological fluids
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences
11/16/1995WO1995030761A2 Methods of in vivo gene delivery
11/16/1995WO1995030759A1 Biologically active polypeptides inserted into an albumin
11/16/1995WO1995030758A1 Recombinant hk2 polypeptide
11/16/1995WO1995030757A2 Metalloproteases from fusarium and aspergillus having thermolysin-like activity
11/16/1995WO1995030756A1 Thermostable alkaline phosphatase of thermus thermophilus
11/16/1995WO1995030755A1 Recombinant human immunodeficiency virus vector and process for producing the same
11/16/1995WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof
11/16/1995WO1995030753A1 CHIMERIC DELTA-ENDOTOXIN EXPRESSION IN $i(PSEUDOMONAS FLUORESCENS)
11/16/1995WO1995030752A1 IMPROVED BACILLUS THURINGIENSIS δ-ENDOTOXIN
11/16/1995WO1995030751A1 Lanthionine-containing antimicrobial compound
11/16/1995WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
11/16/1995WO1995030748A2 Plant u14 nucleic acid sequences and derivatives thereof
11/16/1995WO1995030747A1 Plant u14 nucleic acid sequences and derivatives thereof
11/16/1995WO1995030746A1 Antisense inhibition of hepatitis c virus
11/16/1995WO1995030744A2 Lipases with improved surfactant resistance
11/16/1995WO1995030743A1 Protease variants
11/16/1995WO1995030741A1 Receptor-deficient animals and cell lines derived therefrom, and uses thereof
11/16/1995WO1995030739A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi
11/16/1995WO1995030695A1 Interleukin-15 receptors
11/16/1995WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995WO1995030686A1 Production of biologically active recombinant neurotrophic protein
11/16/1995WO1995030685A1 An enzymatic process for producing a desired protein from an amino terminal extended protein
11/16/1995WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995030339A1 Cloning, expression, and uses of human lactoferrin
11/16/1995WO1995030330A1 Method for in vivo delivery of therapeutic agents via liposomes
11/16/1995WO1995027080A3 Dna sequencing by stepwise ligation and cleavage
11/16/1995WO1995025801A3 Viral replicon